by Brooks | Feb 12, 2025 | Emerging Trends, Reduce Adverse Drug Reactions
Raymond A. Lorenz, PharmD, BCPP & Niharika Koppulu Pharmacogenomics-Enriched Comprehensive Medication Management: A Retrospective Cohort Study. Did you know over 99% of patients have genetic variations impacting their response to drugs (Chanfreau-Coffinier, et al....
by Brooks | Jan 8, 2025 | Emerging Trends, Reduce Adverse Drug Reactions
Jayden Lee, PharmD & Zachary S. Brooks, PhD A New Way to Get Medications: Next Generation Sequencing for You. How do you currently get your medications? You see a doctor who diagnoses you, then receive a prescription. Your pharmacist performs a second check to...
by Brooks | Dec 30, 2024 | Emerging Trends, Reduce Adverse Drug Reactions
Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD The Transformative Potential of Phenoconversion in Pharmacogenomics. What is phenoconversion, and why is it pivotal in the realm of pharmacogenomics (PGx)? An exploration of phenoconversion, PGx mechanisms, and...
by Brooks | Dec 29, 2024 | Emerging Trends, Reduce Adverse Drug Reactions
Husna Rahim, PharmD & Kate Choy-Kay Lee Exploring Genetic Variations in Drug Metabolism. How do genetic variations influence drug metabolism and patient response to therapy? Genetic variations, also known as polymorphisms, can significantly affect how an...
by Brooks | Dec 27, 2024 | Emerging Trends, Reduce Adverse Drug Reactions
Husna Rahim, PharmD & Jennifer Tovar PharmD Minimizing risks of Drug Reactions Pharmacogenomics. Your Reliable results. How does implementing pharmacogenomics in patient care reduce the incidence of adverse drug reactions? Pharmacogenomics (PGx) involves the study...
by Brooks | Dec 27, 2024 | Emerging Trends, Reduce Adverse Drug Reactions
Jayden Lee, EMBA, PharmD, BCACP & Zachary S. Brooks, PhD, EMBA What’s the first thing you think of when you hear the word “pharmacogenomics”? What is the purpose of most pharmacogenomic research? If you think about how your body processes the medications you take,...
